The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Robert Svatek
No Relationships to Disclose
 
Catherine Tangen
No Relationships to Disclose
 
Joshua Meeks
Honoraria - Astellas Pharma; AstraZeneca; bristol meyers; CG Oncology; ferring; ImmunityBio; Imvax; Janssen; Merck; Pfizer; Photocure; Prokarium; Protara Therapeutics; Urogen pharma
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Scott Gilbert
No Relationships to Disclose
 
Yair Lotan
Stock and Other Ownership Interests - CAPs medical; Nanorobotics; Phinomics; trigone pharma; Uroviu; vesica health; Vessi Medical; Virtuoso Therapeutics
Consulting or Advisory Role - Abbvie; Ambu; AstraZeneca; Aura Biosciences; BMS; caps medical; Cleveland Diagnostics; Convergent Genomics; Fergene; ImmunityBio; Janssen; Merck; Nanogen Biopharmaceutical; Nanorobotics; nrx pharmaceuticals; Nucleix; pacific edge; phinomics; Photocure; Seagen; Stimit; trigone pharma; Urogen pharma; uroviu; verity pharmaceuticals; Vessi Medical; virtuoso surgical; Xcures
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); storz (Inst)
 
Mark Tyson
Consulting or Advisory Role - AstraZeneca; enGene; Ferring; ImmunityBio; Protara Therapeutics
Research Funding - AstraZeneca (Inst); CG Oncology (Inst); enGene (Inst); Ferring (Inst); ImmunityBio (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); NCI (Inst); pacific edge (Inst); Protara Therapeutics (Inst); Seagen (Inst); SWOG (Inst); Urogen pharma (Inst)
 
Paul Crispen
No Relationships to Disclose
 
Scott Delacroix
No Relationships to Disclose
 
Jessie Gills
No Relationships to Disclose
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Allergan (I); AstraZeneca; Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson; Lilly; pacific edge; Pfizer; Photocure; Protara Therapeutics; Storz; Urogen pharma
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Pfizer; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; pacific edge; Pfizer; Photocure; Taris; Urogen pharma; UroToday
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Michael Woods
No Relationships to Disclose
 
Viraj Master
Honoraria - Ethicon; Exelixis
Research Funding - Exelixis; Merck (Inst)
 
J. Mark
No Relationships to Disclose
 
Ajjai Alva
No Relationships to Disclose
 
Rick Bangs
Honoraria - Astellas Pharma; AstraZeneca; Gilead Sciences; Pfizer
Consulting or Advisory Role - CVS Health; Gilead Sciences; Janssen Oncology; Nonagen Bioscience
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Gilead Sciences; Janssen Oncology; Pfizer
Other Relationship - Bladder Cancer Advocacy Network; National Cancer Institute; SWOG; SWOG; SWOG
(OPTIONAL) Uncompensated Relationships - Genentech; Gilead Sciences
 
Darrell Nakagawa
Leadership - Bladder Cancer Advocacy Network
Honoraria - Tyra Biosciences
 
Joseph Unger
Consulting or Advisory Role - AstraZeneca; Loxo/Lilly
Research Funding - Arnold Ventures
 
Melissa Plets
No Relationships to Disclose
 
Ian Thompson
Employment - CHRISTUS Health
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Seth Lerner
Stock and Other Ownership Interests - Aura Biosciences; C2i genomics
Honoraria - Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; Ferring; Gilead Sciences; ImmunityBio; Protara Therapeutics; SURGE Therapeutics; Trigone Pharma; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Aura Biosciences; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; SURGE Therapeutics; Vaxiion
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate